Results 251 to 260 of about 6,254,959 (286)
Some of the next articles are maybe not open access.

The chemistry, pharmacology and clinical pharmacology of diflunisal

Current Medical Research and Opinion, 1978
Studies are reviewed on diflunisal, a new analgesic agent with an improved therapeutic index, compared with acetylsalicylic acid, in animals and humans. Pharmacokinetic data indicate that a twice-daily dosage regimen of diflunisal is adequate for therapeutic purposes.
S L, Steelman   +2 more
openaire   +2 more sources

Clinical Pharmacology

JAMA: The Journal of the American Medical Association, 1989
The issue of what drug effects to measure, surrogate end points, has been emphasized by two recent clinical trials. Several recent studies have given us new information about why different people react so differently to the same dose of the same medicine.
openaire   +5 more sources

Pharmacology and Clinical Pharmacology of Vigabatrin

Journal of Child Neurology, 1991
Vigabatrin is an enzyme-activated, irreversible inhibitor of γ-aminobutyric acid (GABA) aminotransferase, which causes a marked increase in cerebral GABA concentration and a resulting anticonvulsant action. Recovery from its effects requires the synthesis of new enzyme, and this may take several days following a single dose.
openaire   +2 more sources

Clinical Pharmacology of Lacidipine

Journal of Cardiovascular Pharmacology, 1991
The safety and tolerability of lacidipine was assessed in a volunteer population, and its pharmacodynamic and pharmacokinetic profiles evaluated. In normotensive subjects, single oral doses of 3-5 mg of lacidipine produced a dose-related fall in peripheral vascular resistance.
S T, Hall   +4 more
openaire   +2 more sources

Clinical pharmacology in Australia

Clinical Pharmacology & Therapeutics, 1974
In Australia, clinical pharmacology is a small but developing discipline useful for the generation of data concerning the efficacy and safety of new therapeutic substances. While most clinical pharmacology is carried on as an adiunct to the interests of a specialist in some branch of internal medicine, there are now, in Australia, four units titled ...
openaire   +4 more sources

Clinical pharmacology

To design therapeutic trials and select the most appropriate substance and dose for an indication, a detailed understanding of clinical pharmacology is crucial. In recent years, several studies have explored the human pharmacology of different psychedelics and 3,4-methylendioxymethylamphetamin (MDMA).
Severin B, Vogt, Matthias E, Liechti
openaire   +2 more sources

CLINICAL PHARMACOLOGY OF BENZODIAZEPINES

Annual Review of Medicine, 1987
The benzodiazepines are the most widely used anxiolytic drugs. Their pharmacokinetic properties differ widely. Side effects are usually mild but dependence can supervene after long-term administration, even if normal therapeutic doses are not exceeded. Careful monitoring of use is essential.
openaire   +2 more sources

Pharmacology and clinical pharmacology of organic nitrates

European Journal of Clinical Pharmacology, 1990
Current concepts and future aspects of pharmacological interventions in the treatment of coronary heart disease have been compiled. Especially new insights in the pathophysiology of coronary heart disease e.g. the dynamic pathology of coronary atherosclerosis, possible role of endothelin in vasospasm, as well as new pharmacodynamic and pharmacokinetic ...
openaire   +2 more sources

Clinical pharmacology of thalidomide

European Journal of Clinical Pharmacology, 2001
Thalidomide has a chiral centre, and the racemate of (R)- and (S)-thalidomide was introduced as a sedative drug in the late 1950s. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide due to its unique anti-inflammatory and immunomodulatory effects.To critically review pharmacokinetic ...
T, Eriksson, S, Björkman, P, Höglund
openaire   +2 more sources

Clinical pharmacology and malaria

Annals of Tropical Medicine And Parasitology, 1997
The role of clinical pharmacology in improving the prevention and treatment of malaria is reviewed. A series of general and specific issues is discussed, concentrating on risk-benefit and cost-effectiveness. The techniques of clinical pharmacokinetics play an important role in the optimal use of drugs and this is illustrated by studies on quinine and ...
A M, Breckenridge, P A, Winstanley
openaire   +2 more sources

Home - About - Disclaimer - Privacy